Loading company…
Riskpilot
← Back to search
Sign in
Get full access
MSH INNOVATIONS AB
AB
Active
Org 5593392334
Rödabergsgatan 6
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2021
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 2,2M
+712% vs 2024
EBITDA margin
90.4%
+1985% vs 2024
Equity ratio
49.2%
Financial strength
Net profit 2025
SEK 1,2M
+1155% vs 2024
EBITDA — year on year
SEK millions
3M
2M
1M
1M
0M
0M
2022
0M
0%
2023
0M
0%
2024
2M
+200%
2025
Key figures
Annual report 2025
Revenue
SEK 2,2M
+712%
EBITDA
SEK 2M
+1985%
Net profit
SEK 1,2M
+1155%
Total assets
SEK 2,5M
+1125%
Equity
SEK 1,2M
+765%
Employees
0
—
Company information
Legal name
MSH INNOVATIONS AB
Org number
5593392334
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
7 oktober 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-07-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget skall utveckla och bedriva handel med medicinteknisk utrustning.
Contact
Address
Rödabergsgatan 6
Email
settergren.rmm@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
0M
2022
0M
2023
0M
2024
2M
2025
EBITDA
SEK millions
0M
1M
1M
2M
2M
0M
2022
0M
2023
0M
2024
2M
2025
Income statement
SEK thousands
Item
2022
2023
2024
2025
Revenue
—
—
270
2 193
Staff expenses
—
—
—
—
EBITDA
−68
−100
95
1 981
Depreciation & amort.
—
—
—
—
EBIT
−68
−100
95
1 981
Net financials
—
−1
1
−8
Profit before tax
−68
−100
96
1 498
Tax
—
—
—
−294
Net profit
−68
−100
96
1 204
Balance sheet
SEK thousands
Item
2022
2023
2024
2025
Total assets
120
41
205
2 515
Equity
37
27
143
1 237
Long-term debt
—
—
—
—
Short-term debt
82
14
62
802
Total debt
82
14
62
802
Financial ratios
5-year trend
EBITDA margin
90.4%
This company
15.8%
Market median
+472% vs market
2022
2025
Equity ratio
49.2%
This company
38.2%
Market median
+29% vs market
2022
2025
Return on equity
97.3%
This company
18.4%
Market median
+429% vs market
2022
2025
Net profit margin
54.9%
This company
8.1%
Market median
+578% vs market
2022
2025
Asset turnover
0.87×
This company
1.12×
Market median
+22% vs market
2022
2025
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-08-01 – 2025-07-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-08-01 – 2024-07-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-08-01 – 2023-07-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-10-07 – 2022-07-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MJ
Magnus Jansson Settergren
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
CE
Camilla Elisabeth E Settergren
Deputy Board Member
2022
SH
Staffan Holmin
Chairman
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of MSH INNOVATIONS AB also hold positions in
0
other companies.
Person
Role here
Other companies
Magnus Jansson Settergren
Chief Executive Officer
0 companies
Camilla Elisabeth E Settergren
Deputy Board Member
0 companies
Staffan Holmin
Chairman
0 companies